Quest PharmaTech Inc. (TSXV:QPT)

Quest PharmaTech Balance Sheet

Financials in millions CAD. Fiscal year is February - January.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 31, 2025	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Cash & Equivalents	0.06	0.21	0.72	0.37	0.26	0.2
Cash & Short-Term Investments	0.06	0.21	0.72	0.37	0.26	0.2
Cash Growth	-68.75%	-71.39%	91.36%	41.73%	32.76%	-91.88%
Accounts Receivable	-	-	-	-	-	0.03
Other Receivables	-	-	0.1	0.22	0	-
Total Trade Receivables	-	-	0.1	0.22	0	0.03
Other Current Assets	0.03	0.02	0.02	0.03	0.02	0.05
Total Current Assets	0.08	0.23	0.84	0.62	0.29	0.28
Net Property, Plant & Equipment	-	-	-	0	0.02	0.06
Long-Term Investments	24.24	22.33	23.63	26.17	90.71	175.27
Other Long-Term Assets	24.26	22.34	23.65	26.19	90.75	175.34
Total Assets	24.33	22.56	24.48	26.8	91.03	175.61
Accounts Payable	0.25	0.17	0.32	0.11	0.11	0.09
Short-Term Debt	1	1	1	1	0.5	0.25
Current Portion of Leases	-	-	-	-	0.01	0.04
Total Current Liabilities	1.25	1.17	1.32	1.11	0.62	0.38
Long-Term Leases	-	-	-	-	-	0.01
Total Long-Term Liabilities	-	-	-	-	-	0.01
Total Liabilities	1.25	1.17	1.32	1.11	0.62	0.39
Common Stock	30.74	30.74	30.74	30.74	30.62	30.62
Additional Paid-in Capital	11.77	11.69	11.6	11.13	11.06	10.79
Accumulated Other Comprehensive Income	-0.14	-0.15	-0.11	-0.11	-0.05	-
Retained Earnings	-19.29	-20.88	-19.08	-16.06	48.78	133.81
Total Common Shareholders' Equity	23.08	21.4	23.15	25.7	90.41	175.22
Shareholders' Equity	23.08	21.4	23.15	25.7	90.41	175.22
Total Liabilities & Equity	24.33	22.56	24.48	26.8	91.03	175.61
Total Debt	1	1	1	1	0.51	0.3
Net Cash (Debt)	-0.94	-0.79	-0.28	-0.63	-0.25	-0.11
Net Cash Per Share	-0.01	-0.01	-0.00	-0.00	-0.00	-0.00
Book Value	23.08	21.4	23.15	25.7	90.41	175.22
Book Value Per Share	0.14	0.13	0.14	0.15	0.54	1.04
Tangible Book Value	23.08	21.4	23.15	25.7	90.41	175.22
Tangible Book Value Per Share	0.14	0.13	0.14	0.15	0.54	1.04

Updated Oct 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.